- Home
- ALTO vs BNTC Comparison
ALTO vs BNTC Comparison
Compare ALTO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALTO | BNTC |
|---|---|---|
| Founded | 2003 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.7M | 313.9M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ALTO | BNTC |
|---|---|---|
| Price | $3.44 | $8.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $8.33 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 996.4K | 187.5K |
| Earning Date | 11-04-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.51 | 6.67 |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $917,927,000.00 | N/A |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $1.09 | N/A |
| P/E Ratio | $18.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $8.25 |
| 52 Week High | $6.11 | $16.76 |
Technical Indicators
Market Signals| Indicator | ALTO | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 32.84 | 28.71 |
| Support Level | $2.43 | N/A |
| Resistance Level | $4.17 | $14.09 |
| Average True Range (ATR) | 0.13 | 0.62 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 1.32 | 4.83 |
Price Performance
Historical ComparisonAbout ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.